References
- Ekström B, Fellner H. Antibacterial activity of co-trimazine in vitro and in vivo. Infection 1979; 7: 74–80
- Bergan T, Vik-Mo H, Ånstad U. Kinetics of a sulfadiazine-trimethoprim combination. Clin Pharmacol Ther 1976; 22: 211–224
- Örtengren B, Fellner H, Bergan T. Development of sulphonamide-trimethoprim combinations for urinary tract infection. Part 2: Comparative pharmacokinetics of five sulphonamides. Infection 1979; 7: 367–370, Suppl. 4
- Sietzen W, Rugendorff E W. Co-trimazine once daily in urinary tract infections in comparison with co-trimoxazole given twice daily—a double-blind randomized study. Infection 1981; 9: 91–95
- Adam D, Hager C, Dorn G, Bamberg P. A comparison of co-trimazine once daily and co-trimoxazole twice daily in treatment of urinary tract infections in children. J Antimicrob Chemother 1982; 10: 453–458
- Aarbakke J, Opshaug O, Digranes A, Høylandskjær A, Fluge G, Fellner H. Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections. Eur J Clin Pharmacol 1983; 24: 267–271
- Rieder J. Quantitative demonstration of the bacteriostatically active fraction of sulphonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy 1972; 17: 1–21
- Örtengren B, Treiber L R. In situ quantitative evaluation of thin layer chromatograms in clinical and pharmaceutical analysis. I. Estimation of some sulfonamide derivatives in human urine. Res Commun Chem Pathol Pharmacol 1974; 9: 339–357